Recent FDA Approval of Advanced Treatment for Patients with Metastatic Non Small-Cell Lung Cancer (NSCLC) Demonstrates Importance of Participation in Clinical Trials
December 06, 2022 15:41 ET
|
Florida Cancer Specialists & Research Institute
Ft. Myers, Fla., Dec. 06, 2022 (GLOBE NEWSWIRE) -- A clinical study conducted with participation by Florida Cancer Specialists & Research Institute, LLC (FCS) has led to FDA approval of a new...
WHILL Power Chairs Announces Partnership With Stealth Products
October 24, 2022 12:00 ET
|
WHILL Inc.
SAN FRANCISCO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- WHILL, Inc., award-winning provider of electric mobility chairs, and Stealth Products LLC, announced a new partnership whereby seating and...
Berkshire Sterile client receives FDA approval on product indicated to reduce risk of hearing loss for childhood cancer patients
September 29, 2022 11:00 ET
|
Berkshire Sterile Manufacturing
Lee, MA, Sept. 29, 2022 (GLOBE NEWSWIRE) -- On September 21st, 2022, Berkshire Sterile Manufacturing’s (BSM) client, Fennec Pharmaceuticals Inc., received FDA approval of their drug product, PEDMARK...
FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older
July 29, 2022 16:05 ET
|
Arcutis Biotherapeutics, Inc.
First and only topical PDE4 inhibitor approved for the treatment of plaque psoriasis, including intertriginous psoriasis Approved for once-daily treatment in mild, moderate, and severe plaque...
Neovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient Populations
July 26, 2022 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, July 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced the United States Food and Drug...
Aussie Company Care A2+ Gains FDA Approval to Address US Infant Formula Shortages
July 09, 2022 09:00 ET
|
Care A2+
SYDNEY, July 09, 2022 (GLOBE NEWSWIRE) -- Care A2+, an Australian health and wellness company, today announced it has been approved by the United States Food & Drug Administration (FDA) to...
FDA Approves Sientra’s Low Plus Profile Projection Breast Implant
July 06, 2022 09:00 ET
|
Sientra, Inc.
SANTA BARBARA, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) approved the Low...
Spero Class Action Complaint Filed: Johnson Fistel, Globally Recognized Law Firm, Encourages Shareholders to Submit Their Losses
May 26, 2022 17:21 ET
|
Johnson Fistel, LLP
SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Spero Therapeutics, Inc....
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Positive Preliminary Results of Validcare CBD Safety Study
May 18, 2022 09:00 ET
|
Medical Marijuana, Inc.
SAN DIEGO, CA, May 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that...
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ TRIPLE PAK™ (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA™ DUAL PAK™ (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults
May 03, 2022 17:40 ET
|
Phathom Pharmaceuticals
VOQUEZNA TRIPLE and DUAL PAKs each contain vonoprazan, a novel, first-in-class potassium-competitive acid blocker (PCAB), and have demonstrated superior eradication rates vs. lansoprazole-based triple...